190 related articles for article (PubMed ID: 36294202)
1. Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells.
Noureldeen AFH; Aziz SW; Shouman SA; Mohamed MM; Attia YM; Ramadan RM; Elhady MM
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294202
[TBL] [Abstract][Full Text] [Related]
2. Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents.
Sabbah DA; Al-Tarawneh F; Talib WH; Sweidan K; Bardaweel SK; Al-Shalabi E; Zhong HA; Abu Sheikha G; Abu Khalaf R; Mubarak MS
Med Chem; 2018; 14(7):695-708. PubMed ID: 29651943
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
[TBL] [Abstract][Full Text] [Related]
4. Bioactive platinum complex of ligand bearing pyrimidine skeleton: DNA/BSA binding, molecular docking, anticancer, antioxidant and antimicrobial activities.
Sankarganesh M; Adwin Jose PR; Dhaveethu Raja J; Vijay Solomon R; Dorothy Sheela C; Gurusamy S
J Biomol Struct Dyn; 2022 Sep; 40(15):6683-6696. PubMed ID: 33634734
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structural characterization, and biological studies of ATBS-M complexes (M(II) = Cu, Co, Ni, and Mn): Access for promising antibiotics and anticancer agents.
Ismael M; Abdel-Rahman LH; Abou El-Ezz D; Ahmed EA; Nafady A
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000241. PubMed ID: 33336849
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic, Computational, Antimicrobial, DNA Interaction, In Vitro Anticancer and Molecular Docking Properties of Biochemically Active Cu(II) and Zn(II) Complexes of Pyrimidine-Ligand.
Sankarganesh M; Dhaveethu Raja J; Adwin Jose PR; Vinoth Kumar GG; Rajesh J; Rajasekaran R
J Fluoresc; 2018 Jul; 28(4):975-985. PubMed ID: 29961205
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.
Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
11. Design, spectral characterization, thermal, DFT studies and anticancer cell line activities of Co(II), Ni(II) and Cu(II) complexes of Schiff bases derived from 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol.
Tyagi P; Chandra S; Saraswat BS; Yadav D
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jun; 145():155-164. PubMed ID: 25770965
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
13. New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway.
Noser AA; Abdelmonsef AH; El-Naggar M; Salem MM
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500765
[TBL] [Abstract][Full Text] [Related]
14. New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity.
Zehra S; Shavez Khan M; Ahmad I; Arjmand F
J Biomol Struct Dyn; 2019 Apr; 37(7):1863-1879. PubMed ID: 29676660
[TBL] [Abstract][Full Text] [Related]
15. A coordinated ruthenium-rifampicin complex reprogramming the colon carcinoma micro-environment mediated by modulation of p53/AkT/mTOR/VEGF pathway.
Zeng J; Zhao Y; Li K; Long D; Li W; Liang L
Toxicol Appl Pharmacol; 2021 Sep; 426():115618. PubMed ID: 34126112
[TBL] [Abstract][Full Text] [Related]
16. Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways.
Roy S; Mondru AK; Chakraborty T; Das A; Dasgupta S
Toxicol Appl Pharmacol; 2022 Jan; 434():115822. PubMed ID: 34896434
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
18. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
19. A newly synthesized thiosemicarbazide derivative trigger apoptosis rather than necroptosis on HEPG2 cell line.
Başoğlu-Ünal F; Becer E; Ensarioğlu HK; -Güzeldemirci NU; Kuran ED; Vatansever HS
Chem Biol Drug Des; 2024 Jan; 103(1):e14355. PubMed ID: 37776268
[TBL] [Abstract][Full Text] [Related]
20. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.
Chen XL; Fu JP; Shi J; Wan P; Cao H; Tang ZM
Mol Med Rep; 2015 Dec; 12(6):8229-36. PubMed ID: 26496900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
